EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unraveling Tumor Heterogeneity in Gynecological Cancer Using a Radiogenomics Approach

Miriam Dolciami, Veronica Celli, Camilla Panico iD, Konstantinos Zormpas Petridis, Camilla Nero, Maria Chiara Cannizzaro, Alessandra Iacono, Pietro Paolo Maria Azzaro, Giacomo Avesani, Anna Fagotti, Evis Sala

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.04.2026 · 198 (04) · 433-446

DOI: 10.1055/a-2698-8545 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.04.2026. Verfasst von Miriam Dolciami und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Endometrial Neoplasms, Genomics, Imaging Genomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) and endometrial cancer (EC) are highly heterogeneous gynecological malignancies with distinct molecular subtypes, therapeutic responses, and clinical outcomes. Traditional biopsy-based profiling often fails to capture the spatial and temporal complexity of these tumors. Radiogenomics, integrating imaging features with genomic and molecular data, has emerged as a promising approach to non-invasively analyze tumor heterogeneity. The purpose of this abstract is to critically examine and synthesize existing research on the application of radiogenomics in OC and EC, focusing on its ability to correlate imaging phenotypes with molecular biomarkers. This narrative review aims to demonstrate how radiogenomics can enhance tumor characterization, support biomarker prediction, and inform prognosis and therapeutic decision-making with non-invasive methods. This narrative review critically synthesizes current literature on radiogenomics applications in OC and EC. Studies using CT, MRI, and PET imaging were evaluated for their ability to correlate imaging phenotypes with molecular biomarkers, gene expression profiles, and clinical outcomes. The analysis emphasizes the role of radiogenomics in enhancing tumor characterization, predicting biomarker status, forecasting treatment response and prognosis. Radiogenomics has successfully identified associations between imaging features and key molecular alterations, such as BRCA mutations, homologous recombination deficiency (HRD), and immune-related biomarkers in OC, as well as POLE mutations, microsatellite instability (MSI), and tumor mutational burden (TMB) in EC. Predictive models incorporating radiomic features have demonstrated notable performance in estimating prognosis, treatment response, and recurrence risk across both cancer types. Radiogenomics has a strong potential to enhance personalized cancer care by analyzing tumor heterogeneity. However, clinical application requires methodological standardization, prospective validation, and integration into precision oncology workflows.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsEndometrial NeoplasmsGenomicsImaging GenomicsGenital Neoplasms, FemaleHumansFemaleBiomarkers, TumorPrognosisMagnetic Resonance ImagingTomography, X-Ray Computed

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Computational Pathology and Spatial-Integrated Omics GSTeP facility, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Computational Pathology and Spatial-Integrated Omics GSTeP facility, Università Cattolica del Sacro Cuore - Campus di Roma, Rome, Italy.
  • Department of Women's and Children's Health Sciences and Public Health, UOC Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Department of Women's and Children's Health Sciences and Public Health, UOC Gynecologic Oncology, Università Cattolica del Sacro Cuore - Campus di Roma, Rome, Italy.
  • Department of Diagnostic Imaging and Radiation Oncology, Università Cattolica del Sacro Cuore - Campus di Roma, Rome, Italy.

ORCID-Profile: Camilla Panico

Zitieren

APA

Dolciami, M., Celli, V., Panico, C., Zormpas Petridis, K., Nero, C., Cannizzaro, M. C., Iacono, A., Azzaro, P. P. M., Avesani, G., Fagotti, A., & Sala, E. (2026). Unraveling Tumor Heterogeneity in Gynecological Cancer Using a Radiogenomics Approach. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 198(04), 433-446. https://doi.org/10.1055/a-2698-8545

Vancouver

Dolciami M, Celli V, Panico C, Zormpas Petridis K, Nero C, Cannizzaro MC, et al. Unraveling Tumor Heterogeneity in Gynecological Cancer Using a Radiogenomics Approach. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2026;198(04):433-446. doi:10.1055/a-2698-8545

BibTeX
@article{Dolciami2026,
  author = {Dolciami, Miriam and Celli, Veronica and Panico, Camilla and Zormpas Petridis, Konstantinos and Nero, Camilla and Cannizzaro, Maria Chiara and Iacono, Alessandra and Azzaro, Pietro Paolo Maria and Avesani, Giacomo and Fagotti, Anna and Sala, Evis},
  title = {Unraveling Tumor Heterogeneity in Gynecological Cancer Using a Radiogenomics Approach},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year = {2026},
  volume = {198},
  number = {04},
  pages = {433--446},
  doi = {10.1055/a-2698-8545}
}
Kostenlos starten →